一种肠球菌菌体蛋白广泛抑制了参与抗菌体防御的IV型限制酶
Nathan P Bullen1,2, Cydney N Johnson3, Shelby E Andersen3
1Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada, L8S 4L8.
bioRxiv : the preprint server for biology
|November 28, 2023
概括
研究人员在多药耐药的Enterococcus faecalis中发现了一种新的防御系统,该系统阻断了菌体治疗. 他们还发现了菌体如何进化以克服这种抵抗力,为开发有效的菌体治疗提供了见解.
科学领域:
- 微生物学和病毒学
- 细菌遗传学和耐药性机制
- 开发抗微生物疗法 开发抗微生物疗法
背景情况:
- 越来越多的抗药性 (MDR) 细菌感染,特别是MDR肠球菌的流行率,对全球健康构成重大威胁.
- 抗生素的开发正在滞后,需要替代治疗策略,如菌体 (菌体) 治疗.
- 了解MDR细菌中的菌体耐药机制对于菌体治疗的成功至关重要.
研究的目的:
- 确定导致菌体抗 *Enterococcus faecalis* 的遗传因素.
- 阐明E. faecalis抵抗特定菌体的机制.
- 研究菌体用来克服细菌耐药性的进化策略.
主要方法:
- 使用CRISPR干扰 (CRISPRi) 基因选来识别E. faecalis*中的菌体耐药性决定因素.
- 标志着一种新型的等离子体传播的遗传局部编码IV型限制酶 (TIV-RE).
- 通过全基因组测序和功能测试分析了菌体进化,以确定破坏耐药性的突变.
主要成果:
- 在可调动等离子体上确定了一个基因位点,使E. faecalis*对菌体phi47产生抵抗力.
- 证明已识别的位点编码了一个限制菌体复制的TIV-RE.
- 发现菌素phi47通过获得IV型限制抑制因子A (TifA) 的TIV-RE抑制剂的突变而发展出耐药性,该突变抑制了各种TIV-RE.
结论:
- 对抗药物*Enterococcus faecalis*的菌体防御机制的高级理解.
- 提供了关于细菌菌体如何进化以克服细菌抗菌体防御系统的机制性见解.
- 这些发现有助于合理设计针对MDR细菌感染的菌体治疗策略.
相关概念视频
Restriction Enzymes
30.7K
Restriction enzymes are bacterial enzymes used to cut DNA in a sequence-specific manner. To cleave DNA, they bind to specific palindromic sequences called restriction sites. Such palindromic DNA sequences or inverted repeats are commonly found in regions of functional significance, such as the origin of replication, gene operator sites, and regions containing transcription termination signals.
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
30.7K
Lysogenic Cycle of Bacteriophages
62.2K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
62.2K
Lytic Cycle of Bacteriophages
70.8K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.8K
CRISPR and crRNAs
17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K
Eukaryotic Transcription Inhibitors
9.8K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.8K


